Transcendent Capital Group LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Transcendent Capital Group LLC

  • $195 Billion
  • Q3 2024

A detailed history of Transcendent Capital Group LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Transcendent Capital Group LLC holds 120 shares of XBI stock, worth $11,548. This represents 0.01% of its overall portfolio holdings.

Number of Shares
120
Previous 17,664 99.32%
Holding current value
$11,548
Previous $1.64 Billion 99.28%
% of portfolio
0.01%
Previous 0.94%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$90.87 - $102.43 $1.59 Million - $1.8 Million
-17,544 Reduced 99.32%
120 $11.9 Million
Q2 2024

Jul 24, 2024
BUY
$82.22 - $94.12 $1.45 Million - $1.66 Million
17,664 New
17,664 $1.64 Billion

Others Institutions Holding XBI

# of Institutions
925
Shares Held
101M
Call Options Held
28.4M
Put Options Held
33.4M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Transcendent Capital Group LLC Portfolio

Follow Transcendent Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcendent Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcendent Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email